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간폐증후군은 간질환, 폐환기의 이상으로 야기되는 동맥 저산소혈증, 그리고 광범위한 폐혈관 확장의 3징으로 정의된다. 특히 폐 
모세혈관의 비정상적 확장에 의한 폐동맥과 폐정맥의 직접적인 교통은 우-좌 단락을 야기하며 이로 인한 동맥 저산소증은 호흡 
곤란의 원인이 된다. 조영 심초음파는 비침습적으로 이러한 우-좌 단락을 확인 및 진단할 수 있는 유일한 방법으로 사료된다. 본 
증례는 호흡 곤란을 호소하는 63세의 간경변 환자에서 조영 심초음파를 이용하여 간폐증후군을 진단한 증례이다. 
 
중심 단어：간폐증후군·조영 심초음파·우-좌 단락. 
 
Introduction 
 
The hepatopulmonary syndrome (HPS) is defined as the 
triad of liver disease, pulmonary gas exchange abnormalities 
leading to arterial deoxygenation, and widespread pulmon-
ary vascular dilatation.1) Although both acute and chronic 
liver diseases have been associated with HPS, most comm-
only it is associated with cirrhosis. Portal hypertension seems 
to be the predominant factor related to this syndrome.2) The 
hallmark of pulmonary vascular changes in HPS is dilated 
vessels at the precapillary and capillary level and direct 
arteriovenous communications. This causes right-to-left shun-
ting of blood flow, mismatch between ventilation and per-
fusion, and diffusion limitation. Contrast transthoracic echo-
cardiography may be the only diagnostic test to demonstrate 
right-to-left shunt in these patients.3) It is performed by 
intravenous injection of agitated saline as an echocardiogra-
phic contrast, while visualizing the atria. In the case of HPS, 
contrast appears in the left atrium 2 to 5 s after it is seen in 
the right atrium.  
Case Report 
 
A 63-year-old woman was evaluated for progressively 
worsening exertional dyspnea. Her past medical history was 
unremarkable except liver cirrhosis for 10 years. The elec-
trocardiogram revealed sinus rhythmwith early transition in 
V1. Pulmonary function test was normal. Transthoracic echo-
cardiography showed borderline enlarged left atrium but nor-
mal sized other cardiac chambers with normal left ventri-
cular systolic function (ejection fraction 68%). HPS was 
suspected because of a long history of liver cirrhosis. Contrast 
echocardiography was performed by intravenous injection of 
hand-agitated saline while visualizing the atria. Contrast 
appears in the left atrium 3 to 5 seconds after it is seen in the 
right atrium, suggestive of pulmonary arteriovenous fistula 
(Fig. 1). 
 
Discussion 
 
HPS is defined as the clinical triad of advanced liver 
disease, arterial deoxygenation and intrapulmonary vascular 
dilatation.1) HPS is a well-recognized complication of liver 
cirrhosis, but its pathogenesis is not completely understood. 
It is one of pathophysiologic mechanism that pulmonary ca-
pillary is dilated upto 500 μm (normal range：8-15 μm) 
and the vascular resistance reduced, so abnormal hyperdy-
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namic pulmonary circulation results in shunting of deoxy-
dized venous blood into systemic arterial network. Excessive 
pulmonary nitric oxide production seems to be one of the 
factors that contribute to the intrapulmonary vascular dilata-
tion. Other mediators such as endothelin-1 and the heme 
oxygenase-1/carbon monoxide system have recently been 
found to be important contributors.4) 
The prevalence of HPS among patients with liver 
cirrhosis has been reported to be between 5.3 and 17.5%.5)6) 
HPS may also occur in liver diseases such as acute viral 
hepatitis and fulminant hepatic failure.7)8) A few cases with 
noncirrhotic portal hypertension complicated by HPS has 
also been re-ported.9)10) 
The major clinical manifestations are arterial hypoxemia, 
clubbed fingers and spider nevi. Orthodeoxia is also the char-
acteristic clinical feature.  
For the detection of intrapulmonary vascular dilatations 
and shunting, contrast echocardiography is the method of 
choice because it is of easy execution and it can differentiate 
between the intrapulmonary and intracardiac communica-
tions.3)11) In the case of HPS, contrast appears in the left 
atrium 2 to 5 s after it is seen in the right atrium, while si-
multaneously or within 2 heart beats in intracardiac shunt. 
Our case was also approved by hand-agitated saline contrast 
echocardiography. 
99m Technetium macroaggregated albumin (Tc-99m 
MAA) lung perfusion scan can further specify the diagnosis 
of HPS and quantify the magnitude of shunting. On the other 
hand, Koksal and collegues have reported that high resolu-
tion computed tomography (HRCT) may be helpful in the 
diagnosis of HPS by demonstrating the dilated peripheral pul-
monary vessels or increased pulmonary artery to bronchus 
ratios in patients with liver disease and hypoxemia.12) 
Despite of multifarious trial, no clearly effective medical 
treatments have been found. Although liver transplantation 
seems feasible to reverse this situation,11) it is associated with 
increased postoperative morbidity and mortality. Swanson et 
al reported that preoperative arterial oxygen tension of 50 
mmHg or less and Tc-99m MAA shunt fractions of 20% or 
more are strong predictors of postoperative mortality that 
can be used to stratify patients with better outcome.13) There-
fore, early detection of HPS can be related with reduction of 
morbidity and postoperative mortality. 
 
KEY WORDS：Hepatopulmonary syndrome·Contrast ec-
hocardiography·Right-to-left shunt. 
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